Verified analytical markers, multi-compendial testing, and bulk active supply qualified for dietary supplements, functional food, and pharmaceutical formulations.
Addressing thermal stability hurdles, gastric transit survival, and high-density industrial fermentation bottlenecks across modern bioprocessing.
Standard probiotic powders typically lose up to 3-logs of viability during ambient warehousing and low-pH gastric passage. Our multi-layer lipid-matrix coating shields bacterial membranes against bile salts and gastric acid (pH 1.5–2.0), ensuring targeted ileal release above 90% viability.
By implementing real-time optical density (OD600) monitoring, dissolved oxygen control, and automated alkaline neutralization, our computerized bio-reactors reach upwards of 5.0×10¹¹ CFU/g pure unformulated active harvest without inducing early bacterial sporulation or cell lysis.
Every industrial production run of our Lactobacillus paracasei raw material is certified via 16S rRNA gene sequencing and Whole Genome Sequencing (WGS). This prevents genomic drift, antibiotic-resistance transferability, and ensures verifiable taxonomic pedigree for drug master files.
Navigating cost structures, capacity allocation, cold-chain dependency mitigation, and regional regulatory acceptance.
Global procurement teams are shifting focus from simple gross kilogram rates to net active cell viability at target expiry date. Our stabilized ultra-concentrated Lactobacillus paracasei optimizes cost-in-use metrics significantly.
Standard living cultures enforce strict -20°C air freight protocols, adding immense shipping surcharges. Our water-activity-controlled packaging (Aw < 0.15) allows standard dry maritime transit up to 25°C.
Increasing demand in gut-barrier integrity, pediatric atopic dermatitis intervention, and oral care formulations drives a global 14.8% CAGR for dedicated single-strain Lactobacillus paracasei actives.
Turnkey compatibility with major CMO encapsulation facilities. Optimized powder flowability (angle of repose < 30°) facilitates continuous high-speed rotary capsule filling without caking or nozzle blockage.
Every commercial lot of Lactobacillus paracasei is released against verifiable analytical monographs following USP-NF, FCC, and European Pharmacopoeia standards.
| Analytical Parameter | Monograph Standard | Typical Factory Result | Methodology |
|---|---|---|---|
| Identity Verification | Positive for L. paracasei | Conforms (Specific Banding) | 16S rDNA Sequencing / PCR |
| Viable Cell Count | ≥ 3.0 × 10¹¹ CFU/g | 3.25 × 10¹¹ CFU/g | Plate Count (MRS Agar, ISO 7889) |
| Water Activity (Aw) | ≤ 0.20 | 0.12 – 0.14 | Chilled Mirror Dew Point |
| Loss on Drying | ≤ 5.0% | 2.8% | USP <731> (105°C, Constant Wt.) |
| Heavy Metals (Pb, As, Cd, Hg) | ≤ 0.5 ppm each | < 0.05 ppm (Compliant) | ICP-MS (USP <233>) |
| Residual Solvents | Meets USP <467> Category 3 | Not Detected | HS-GC-MS |
| Pathogenic Microorganisms | Absent in 25g (Salmonella, E. coli) | Negative / Absent | FDA BAM Ch. 4 / 5 |
Comprehensive regulatory support dossiers curated to streamline regional FDA NDIs, EFSA Qualified Presumption of Safety (QPS), and global customs audits.
Our Lactobacillus paracasei raw material is backed by comprehensive safety dossiers conforming to 21 CFR Part 190.6 notifications and Self-Affirmed GRAS status, complete with 90-day subchronic oral toxicity clearance.
Documented compliance under the European Food Safety Authority Qualified Presumption of Safety (QPS) list, ensuring friction-free incorporation into functional foods across all 27 EU member states.
Cultivated entirely in animal-free, pork-free, and allergen-screened substrate broths. Fully audited and certified under JAKIM, MUI Halal, and Star-K Kosher authorities for seamless export globally.
Enabling stability across diverse delivery systems, from clinical-grade hard-shell capsules to non-thermal cosmetic emulsions.
Micro-milled particle distribution (D90 < 45 μm) enables seamless integration into oral probiotic lozenges aimed at inhibiting Streptococcus mutans and restoring oral cavity mucosal immunity.
Mitigates the common thermal failure of probiotics during pectin/gelatin dosing (60–65°C depositing phases). Our shielded grade retains >85% live-cell viability throughout gummy extrusion lines.
Available as heat-killed postbiotic lysates or stabilized live suspensions. Clinically documented to suppress Cutibacterium acnes proliferation and reinforce stratum corneum tight junction proteins.
Pioneering cell immobilization, synthetic biology integration, and precision postbiotic isolation technologies.
Deploying continuous hollow-fiber bio-reactors, replacing batch cycles to boost biomass output by 40% while slashing batch-to-batch coefficient of variation under 2.5%.
Refining ultrasonic membrane disruption to harvest standardized pure exopolysaccharides (EPS) and short-chain fatty acid metabolites for pharma-grade anti-inflammatory applications.
Integrating real-time neural network fermentation monitoring to predict metabolic stress responses, guaranteeing optimized ATP-retention prior to deep lyophilization.
Achieving 100% circular biomass utilization by upcycling organic fermentation waste broth into bio-available plant nutrient complexes, meeting strict scope-3 emissions targets.
Key technical insights on viability retention, packaging, and QA auditing protocols.
We pack bulk powders in multi-layer hermetic aluminum foil liners with integrated pharmaceutical molecular sieve desiccant bags, sealed under industrial vacuum with dry nitrogen flushing. This preserves water activity (Aw) below 0.15, safeguarding ambient viability across equatorial transit routes without refrigeration.
Yes. In addition to high-potency concentrates (300B to 500B CFU/g), we formulate standardized premixes with pharmaceutical-grade excipients (maltodextrin, resistant starch, or microcrystalline cellulose) calibrated to precise customer specs (e.g., exactly 10B, 50B, or 100B CFU/g) with exceptional flowability.
Every commercial batch is accompanied by an authenticated Certificate of Analysis (COA) specifying real plate count results, heavy metals (ICP-MS), residual solvents, microbiological purity, and strain identity via 16S sequencing. MSDS, GMO-Free declarations, Allergen-Free certifications, and TSE/BSE statements are provided as standard.
We welcome third-party site audits from recognized international testing authorities (SGS, Eurofins, Intertek) as well as direct virtual or on-site client QA audits at our high-tech fermentation facility in Xi'an.
Factory-direct wholesale ingredients for nutritional formulas, anti-aging solutions, and cosmetic development.